STEAD Trademark

Trademark Overview


On Thursday, January 27, 2022, a trademark application was filed for STEAD with the United States Patent and Trademark Office. The USPTO has given the STEAD trademark a serial number of 97241975. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by GV20 Therapeutics LLC. The STEAD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development; platform as a service services (PAAS) featuring computer software platforms for drug development and discovery
stead

General Information


Serial Number97241975
Word MarkSTEAD
Filing DateThursday, January 27, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development; platform as a service services (PAAS) featuring computer software platforms for drug development and discovery

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGV20 Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02139

Party NameGV20 Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, January 31, 2022NEW APPLICATION ENTERED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 1, 2022ASSIGNED TO EXAMINER
Tuesday, November 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022NON-FINAL ACTION E-MAILED
Monday, June 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 29, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, November 30, 2022ASSIGNED TO LIE
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 3 FILED
Wednesday, July 31, 2024SOU EXTENSION 3 GRANTED
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 24, 2023SOU EXTENSION 1 FILED
Thursday, August 24, 2023SOU EXTENSION 1 GRANTED
Saturday, August 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED